Literature DB >> 25654135

Qualitative and quantitative analysis of the major constituents in Chinese medical preparation Lianhua-Qingwen capsule by UPLC-DAD-QTOF-MS.

Weina Jia1, Chunhua Wang1, Yuefei Wang1, Guixiang Pan1, Miaomiao Jiang1, Zheng Li1, Yan Zhu1.   

Abstract

Lianhua-Qingwen capsule (LQC) is a commonly used Chinese medical preparation to treat viral influenza and especially played a very important role in the fight against severe acute respiratory syndrome (SARS) in 2002-2003 in China. In this paper, a rapid ultraperformance liquid chromatography coupled with diode-array detector and quadrupole time-of-flight mass spectrometry (UPLC-DAD-QTOF-MS) method was established for qualitative and quantitative analysis of the major constituents of LQC. A total of 61 compounds including flavonoids, phenylpropanoids, anthraquinones, triterpenoids, iridoids, and other types of compounds were unambiguously or tentatively identified by comparing the retention times and accurate mass measurement with reference compounds or literature data. Among them, twelve representative compounds were further quantified as chemical markers in quantitative analysis, including salidroside, chlorogenic acid, forsythoside E, cryptochlorogenic acid, amygdalin, sweroside, hyperin, rutin, forsythoside A, phillyrin, rhein, and glycyrrhizic acid. The UPLC-DAD method was evaluated with linearity, limit of detection (LOD), limit of quantification (LOQ), precision, stability, repeatability, and recovery tests. The results showed that the developed quantitative method was linear, sensitive, and precise for the quality control of LQC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25654135      PMCID: PMC4308632          DOI: 10.1155/2015/731765

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


1. Introduction

Lianhua-Qingwen capsule (LQC), developed from the two classical traditional Chinese medicine (TCM) formulae Maxing-Shigan-Tang and Yinqiao-San which have a long history of clinical application in the treatment of influenza [1], is a commonly used Chinese medical preparation to treat viral influenza and especially played an important role in the fight against severe acute respiratory syndrome (SARS) in 2002-2003 in China [2]. LQC is composed of 11 herbs including Fructus Forsythiae (Lianqiao), Flos Lonicerae Japonicae (Jinyinhua), Herba Ephedrae (Mahuang), Semen Armeniacae Amarum (Kuxingren), Radix Isatidis (Banlangen), Rhizoma Dryopteridis Crassirhizomatis (Mianmaguanzhong), Herba Houttuyniae (Yuxingcao), Herba Pogostemonis (Guanghuoxiang), Radix et Rhizoma Rhei (Dahuang), Radix et Rhizoma Rhodiolae Crenulatae (Hongjingtian), and Radix et Rhizoma Glycyrrhizae (Gancao), along with menthol and a traditional Chinese mineral medicine, Gypsum Fibrosum (Shigao). According to previous reports, LQC has a good clinical effect on influenza with the symptoms of high fever, aversion to cold, headache, pharyngalgia, cough, sneezing, muscle ache, and so on [3]. Modern pharmacological studies have shown that LQC also has the antiviral, antibacterial, and anti-inflammatory activities [4, 5]. Recently, the study on its bioactive ingredients and molecular mechanism of action has been gradually reported as well [6]. Although some preliminary analytical methods have been developed for the quality control for LQC, including thin layer chromatography (TLC) [7], high performance liquid chromatography (HPLC) [8, 9], micellar electrokinetic capillary chromatography (MEKC) [10], and liquid chromatography tandem mass spectrometry (LC-MS/MS) [11], no systematical and comprehensive study on the chemical profiling and quality control method for LQC has been reported so far. For a classical and complex Chinese medical preparation, the comprehensive quality evaluation method should be based on its multiple chemical constituents. Therefore, it is necessary to develop a rapid and sensitive method to identify and quantify the chemical constituents in LQC, which will be beneficial to investigate the effectiveness and evaluate the quality of LQC. In this study, a reliable, sensitive, and simple ultraperformance liquid chromatography coupled with diode-array detector and quadrupole time-of-flight mass spectrometry (UPLC-DAD-QTOF-MS) method which was more systematical and comprehensive than the earlier ones was established for characterization and quantification of the major chemical constituents of LQC. A total of 61 compounds were unambiguously or tentatively identified by comparing the retention times, exact molecular masses, and MS/MS spectral data with reference compounds or literature data. Furthermore, twenty-seven compounds were confirmed by comparing with the standards. Among them, twelve representative compounds were quantified as chemical markers in quantitative analysis, including salidroside, chlorogenic acid, forsythoside E, cryptochlorogenic acid, amygdalin, sweroside, hyperin, rutin, forsythoside A, phillyrin, rhein, and glycyrrhizic acid. This is the first systematical and comprehensive study on the qualitative and quantitative analysis of LQC.

2. Experimental

2.1. Reagents, Chemicals, and Materials

Methanol and acetonitrile (HPLC grade) were purchased from Sigma Aldrich (St. Louis, MO, USA). Formic acid (HPLC grade) was purchased from Tianjin Damao chemical reagent factory (Tianjin, China). Water (HPLC grade) for UPLC analysis was produced by the Milli-Q water purification system (Millipore, USA). Salidroside, chlorogenic acid, forsythoside E, cryptochlorogenic acid, amygdalin, sweroside, hyperin, rutin, forsythoside A, phillyrin, rhein, and glycyrrhizic acid were purchased from Sigma Aldrich (St. Louis, MO, USA). The purity of standard substances was above 98%. Ten batches of LQC were provided by Shijiazhuang Yiling Pharmaceutical Co., Ltd. (Shijiazhuang, China).

2.2. UPLC Analysis

The UPLC analysis was performed on a Waters ACQUITY UPLC instrument (Waters Corporation, MA, USA) coupled with a binary pump, a sample manager, an autosampler, a column compartment, and diode-array detector (DAD). The separation of samples was performed on a Waters ACQUITY UPLC BEH C18 (100 × 2.1 mm, 1.7 μm) column with the column temperature at 50°C. The analysis was completed in 30 min with a gradient elution of 0.1% formic acid aqueous solution (A) and methanol (B) at the flow rate of 0.3 mL/min. The gradient program was designed as follows: 0–11 min, 5–35% B; 11–18 min, 35–55% B; 18–22 min, 55–75% B; 22–24 min, 75–90% B; 24-25 min, 90–100% B; and 25–30 min, 100% B. The injection volume was 5 μL. The detection wavelengths of DAD were set at 210 nm, 225 nm, and 254 nm.

2.3. UPLC-DAD-QTOF-MS Analysis

The Waters ACQUITY UPLC instrument (Waters, MA, USA) coupled with Waters Synapt HDMS G1 (Waters, Manchester, UK) via an electrospray ionization (ESI) interface. The UPLC analytical conditions were the same as the UPLC analysis described above. The full scan mass spectra data were acquired in positive and negative ion modes. Acquisition parameters are as follows: capillary voltage was 3000 V for ESI (+) and 2600 V for ESI (−); cone voltage was 45 V; the ESI source temperature was 100°C; the desolvation temperature was 350°C; the nitrogen (N2) was used as desolvation gas at flow rates of 600 L/h for both ESI (+) and ESI (−); and the range of full scan was set at m/z 150–1000 Da. The version of analysis software was Mass Lynx V4.1.

2.4. Sample and Standard Solutions Preparation

The powder of LQC (0.4 g) was accurately weighed and extracted with 60% methanol-water (v/v) solution (20 mL) in an ultrasonic water bath for 30 min at room temperature. The supernatant solution was diluted with the same amount of water and then centrifuged for 10 min at 14,000 r/min. All the obtained solutions were filtered through 0.22 μm syringe filter before the UPLC analysis. Twelve standards were accurately weighed and dissolved in methanol to obtain stock solutions, respectively. A mixed stock solution of standards was prepared by adding a suitable volume of each stock solution to a 5 mL flask and diluted with 30% methanol-water solution at the concentration of 67.8 μg/mL for salidroside, 109.65 μg/mL for chlorogenic acid, 77.64 μg/mL for forsythoside E, 106.47 μg/mL for cryptochlorogenic acid, 62.57 μg/mL for amygdalin, 31.96 μg/mL for sweroside, 3.21 μg/mL for hyperin, 8.5 μg/mL for rutin, 67.34 μg/mL for forsythoside A, 45.71 μg/mL for phillyrin, 55.49 μg/mL for rhein, and 84.35 μg/mL for glycyrrhizic acid, respectively. The mixed stock solution was then serially diluted with 30% methanol-water solution to obtain five appropriate concentrations used for plotting standard curves. The lowest concentration of the mixture stock solution was further diluted to give a series of different concentrations for investigating the limits of detection (LODs) and limits of quantification (LOQs) of the 12 chemical constituents. All solutions were stored at 4°C until analysis.

2.5. Validation of the Quantitative Analysis

The UPLC-DAD method was evaluated with linearity, LOD, LOQ, precision, stability, repeatability, and recovery tests. The calibration curves were constructed with five different concentrations of chemical markers in triplicate. The LODs and LOQs were measured under the UPLC analytical conditions at a signal-to-noise (S/N) ratio of 3 and 10, respectively. For intraday and interday precisions test, the samples were analyzed by six repetitive injections within one day and once a day for three successive days, respectively. At room temperature, the stability of sample solution was evaluated by replicate injection at 0, 1, 2, 4, 6, 8, 10, 14, 24, and 48 h. In order to check the repeatability, six samples from the same source were investigated. Accurate amounts of the reference standards were added to 0.20 g powder of sample in sextuplicate. The resultant sample solutions were then extracted and quantified with the described method. The relative standard deviation (RSD) was used to evaluate the results.

3. Results and Discussion

3.1. Optimization of the Extraction and Chromatographic Conditions

A single-factor method was used to investigate the extraction effect of the extraction solvent (30%, 60%, and 90% methanol-water solution), extraction solvent ratio (1 : 50, 1 : 100, and 1 : 200 (w/v)), and extraction time (15 min, 30 min, and 45 min), respectively. By analyzing the extraction efficiency, 60% methanol-water solution, extraction solvent ratio at 1 : 100, and 30 min of ultrasonic time were selected as the eventual extraction conditions. The results are described in Table 1.
Table 1

Quantitative results of 12 compounds in LQC extracted by different methods.

Content (μg/g)Methods
30%a 60%90%60%60%60%60%60%60%
30 minb 30 min30 min30 min30 min30 min15 min30 min45 min
1 : 100c 1 : 1001 : 1001 : 501 : 1001 : 2001 : 1001 : 1001 : 100
Salidroside1726.281701.251622.021522.311701.251656.321711.541701.251688.54
Chlorogenic acid2444.972492.152216.892285.432492.152289.272492.622492.152552.17
Forsythoside E1583.931620.78451.911462.091620.781402.531627.011620.781579.63
Cryptochlorogenic acid1862.981851.64667.501703.051851.641771.791837.891851.641857.95
Amygdalin1424.111455.391442.561268.931455.391298.111395.971455.391431.38
Sweroside816.19813.18789.32747.06813.18772.67812.51813.18808.24
Hyperin135.10151.73167.26140.84151.73140.80152.72151.73157.67
Rutin122.00121.17115.22106.11121.17116.67117.09121.17116.62
Forsythoside A2484.602536.342661.792285.762536.342396.352543.872536.342521.10
Phillyrin1660.261521.451551.591410.191521.451390.121523.011521.451551.52
Rhein803.131102.061370.11937.631102.06932.05956.381102.061054.77
Glycyrrhizic acid1530.491680.431594.371437.401680.431619.991674.811680.431665.42

aExtracting solvent: 30%, 60%, and 90% methanol-water solution.

bUltrasonic time: 15 min, 30 min, and 45 min.

cExtraction solvent multiples: 1 : 50, 1 : 100, and 1 : 200 expressed 50, 100, and 200 times per gram of sample.

Due to the existence of acidic constituents in sample solutions, formic acid was added into the mobile phase which could inhibit the ionization of these acidic ingredients to improve the peak shape. The mobile phase systems (methanol-formic acid aqueous solution and acetonitrile-formic acid aqueous solution) and column temperature (40°C and 50°C) were investigated, which showed that methanol-0.1% formic acid aqueous solution as mobile phase with column temperature at 50°C could obtain the best chromatographic peak shape. Because the maximum absorptions of 12 reference compounds were different, three detection wavelengths were finally selected in order to achieve the goal of high detection sensitivity and little interference. Forsythoside E (peak 7), cryptochlorogenic acid (peak 9), amygdalin (peak 33), and phillyrin (peak 39) had satisfactory sensitivity at 210 nm, salidroside (peak 6), chlorogenic acid (peak 8), and rhein (peak 54) at 225 nm, and sweroside (peak 13), hyperin (peak 26), rutin (peak 29), forsythoside A (peak 30), and glycyrrhizic acid (peak 57) at 254 nm. The chromatograms are presented in Figure 1.
Figure 1

UPLC-DAD chromatograms of standard solution of 210 nm (a), 225 nm (b), 254 nm (c), negative sample solution (d), and sample solution of 210 nm (e), 225 nm (f), and 254 nm (g).

3.2. UPLC-DAD-QTOF-MS Analysis of Reference Compounds and LQC Samples

As shown in Table 2, a total of 61 compounds were unambiguously or tentatively identified by comparing the retention times and accurate mass measurement with references or literature data. These compounds were divided into six types according to their structural characteristics including flavonoids, phenylpropanoids, anthraquinones, triterpenoids, iridoids, and other types. The structures of identified compounds are listed in Figure 3. Among them, twenty-seven compounds were further confirmed by comparing with standards. The total ion chromatograms are shown in Figure 2.
Table 2

Characterization of compounds in LQC by UPLC-DAD-QTOF-MS.

Peak number T R (min) λ max⁡ (nm)Formula ES (m/z) ES+ (m/z)IdentificationReference
[M–H] (ppm)MS2b [M + H]+(ppm) [M + Na]+ MS2b
1 0.817C7H12O6 191.0555 (−0.5)Quinic acid[12]

2 0.982223, 287C6H8O7 191.0198 (3.1)173.0099 [M–H–H2O], 111.0088 [M–H–2H2O–CO2] Citric acid[13]

3 a 1.545216, 271C7H6O5 169.0142 (3.0)125.0241 [M–H–CO2] Gallic acid[14]

4 a 3.010325C16H17O9 353.0878 (1.4)375.0695 [M–2H + Na], 707.1830 [2M–H] 191.0497 [M–H–Ca], 179.0312 [Caffeic acid–H], 135.0359 [Caffeic acid–H–CO2] Neochlorogenic acid[13]

5 a 3.639254C16H24O10 375.1302 (2.9), 751.2667 [2M–H] 213.0773 [M–H–Glc], 151.0878 [M–H–Glc–CO2–H2O], 125.0721 [M–H–Glc–2CO2] Loganic acid[15]

6 a 4.048224, 278C14H20O7 299.1133 (0.7)179.0447 [M–H–C8H8O], 119.0246 [M–H–Glc–H2O] Salidroside[16]

7 a 4.557C20H30O12 461.1674 (3.3)315.1348 [M–H–Rha], 297.1589 [M–H–Rha–H2O], 153.0644 [M–H–Rha–Glc], 135.0573 [M–H–Rha–Glc–H2O] 463.1220 (−4.3)485.1568137.0599 [M + H–Rha–Glc–H2O]+ Forsythoside E[17]

8 a 4.749327C16H17O9 353.0880 (2.0)191.0556 [M–H–Ca], 179.0224 [Caffeic acid–H] 355.1028 (−0.3)377.0857Chlorogenic acid[18]

9 a 5.281325C16H17O9 353.0880 (2.0)179.0348 [Caffeic acid–H], 173.0461 [Quinic acid–H–H2O], 191.0417 [M–H–Ca] Cryptochlorogenic acid[18]

10 6.435270C17H26O10 389.1096 (3.1)391.2176 (−0.8)413.1067395.2354 [M + Na–H2O]+229.0835 [M + H–Glc]+ Loganin[19]

11 6.749C14H23O9 335.0776 (2.7)173.0459 [M–H–Glc], 161.0373 [Glc–H–H2O], 133.0408 [Glc–H–H2O–CO] 337.0883 (5.3)359.0686163.0419 [Glc + H–H2O]+ Rengynic acid-1′-O-β-D-glucoside[20]

12 7.222C21H20O9 415.1261 (5.1)439.1207255.0879 [M + H–Glc]+ Isomer of chrysophanol glucoside[21]

13 a 7.428245C16H22O9 357.1208 (6.2), 403.1263 [M + HCOO], 393.0938 [M + Cl] 359.1337 (−1.4)381.1154Sweroside[15]

14 7.859C14H23O9 335.0871 (4.2)193.0506, 161.0377, 133.0423337.0774 (0.9)359.0225163.0416 [Glc + H–H2O]+ Isomer of rengynic acid-1′-O-β-D-glucoside

15 8.106306C20H22O8 389.1458 (2.6), 435.1519 [M + HCOO] 227.0943 [M–H–Glc] Polydatin[22]

16 8.222C29H36O16 639.2219 (−1.7)477.1894 [M–H–Glc], 179.0546 [M–Rha–C17H14O6], 161.0328 [Glc–H–H2O],R-suspensaside[23]

17 a 8.320C21H20O9 415.1253 (3.1)253.0542 [M–H–Glc] 417.1394 (−0.7)439.1200255.0864 [M + H–Glc]+ Chrysophanol glucoside[21]

18 8.874C29H36O16 639.2002 (−2.7)161.0328 [Glc–H–H2O], 179.0349 [M–Rha–C17H14O6] S-suspensaside[24]

19 9.054C29H36O15 623.1999 (−1.2)311.2176625.2137 (0.8)647.1942479.1562, 471.1479, 325.0925, 163.0394Isomer of forsythoside A

20 a 9.470235C17H24O11 403.1261 (5.2)405.1331 (−1.7)427.1203243.0871 [M + H–Glc]+ Secoxyloganin[19]

21 9.552276, 313C21H22O9 417.1205 (4.6), 835.2331 [2M–H] 255.0652 [M–H–Glc],441.1132257.0811 [M + H–Glc]+ Liquiritin[25]

22 a 9.886277, 312C26H30O13 549.1627 (3.5)551.2823 (4.7)573.1737257.0822 [M + H–Api–Glc]+ Liquiritin apioside[26]

23 9.995C26H30O13 549.1629 (3.8)551.3403 (−5.1)573.1735257.0815 [M + H–Api–Glc]+ Isomer of liquiritin apioside[26]

24 10.088C27H30O16 609.1844 (−1.8)633.1712Rhodiosin[27]

25 a 10.384250, 300C22H22O9 429.1410 (3.0)453.1176269.0974 [M + H–Glc]+ Ononin[28, 29]

26 a 10.722360C21H20O12 463.0905 (2.8)301.0464 [M–H–Glc] 465.1033 (5.2)487.0333303.0515 [M + H–Glc]+ Hyperin[24]

27 a 10.819326C25H24O12 515.1205 (2.9)353.0751 [M–H–Ca] 517.1296 (1.7)539.1156499.1187 [M + H–H2O]+, 163.0395 [M + H–Ca–Quinic acid]+ 3,5-Dicaffeoylquinic acid[30]

28 10.931C29H36O15 623.1999 (−1.9)461.1378, 161.0185 647.1941471.1497, 325.0925, 163.0415Isomer of forsythoside A

29 a 11.10256, 354C27H30O16 609.1465 (1.5)611.1573 (3.3)633.1404465.0982 [M + H–Rha]+303.0495 [M + H–Rut]+ Rutin[31]

30 a 11.220280C29H36O15 623.2001 (−1.6)461.1920 [M–H–Ca], 161.0328 [Caffeic acid–H–H2O] 647.1927163.0386 [Caffeic acid + H–H2O]+ Forsythoside A[32]

31 11.589283C27H30O15 593.1534 (−1.3)285.0677 [M–H–Rut] 595.1694 (−0.7)287.0936 [M + H–Rut]+ Kaempferol-3-O-rutinoside[13]

32 11.692C19H35O16 519.1884 (3.5), 565.1953 [M + HCOO] 357.1366 [M–H–Glc] 543.1855359.1454 [M + H–Glc]+, 341.1411 [M + H–Glc–H2O]+ (+)-Pinoresinol-β-D-glucoside[33]

33 a 12.213210, 262C20H27NO11 456.1523 (3.7)458.1641 (−4.6)296.1124 [M + H–Glc]+, 162.0862 [M + H–Glc–HCT]+ Amygdalin[13]

34 a 12.659326C25H24O12 515.1162 (−5.4)353.0786 [M–H–Ca] 517.1348 (0.4)539.1193499.1248 [M + H–H2O]+, 163.0387 [M + H–Ca–Quinic acid]+ 3,4-Dicaffeoylquinic acid[30]

35 a 13.082276C15H12O4 255.0654 (−1.2)257.0659 (−0.8)147.0621 [M + H–RL]+, 137.0422 [M + H–VP]+, 119.0691 [M + H–RL–CO]+ Liquiritigenin[34]

36 a 13.251243, 372C26H30O13 549.1621 (2.4)551.1725 (3.4)573.1563419.1360 [M + H–Api]+, 257.0814 [M + H–Api–Glc]+ Isoliquiritin apioside[35]

37 a 13.300242, 362C21H22O9 417.1198 (2.9)255.0518 [M–H–Glc] 419.1314 (−6.7)441.1150257.0823 [M + H–Glc]+, 229.1357 [M + H–Glc–CO]+ Isoliquiritin[26]

38 13.479280C27H34O11 579.2103 [M + HCOO] 557.1987552.2463 [M + NH4]+, 355.1516 [M + H–Glc–H2O]+ Arctiin[36]

39 a 14.161277C27H34O11 579.2106 [M + HCOO] 371.1826 [M–H–Glc], 356.1547 [M–H–Glc–H2O] 552.2444 [M + NH4]+ 557.1991373.1563 [M + H–Glc]+, 355.1544 [M + H–Glc–H2O]+ Phillyrin[37, 38]

40 14.678372, 255C15H10O7 301.0355 (2.3)151.0137 [M–H–C8H6O3] 303.0520 (4.9)Quercetin[39]

41 15.039284C28H34O15 609.1522 (1.3)301.0582 [M–H–Rut] Hesperidin[13]

42 15.402265, 366C15H10O6 285.0406 (2.5)287.0721 (4.5)153.0469 [M + H–HEP]+ Kaempferol[13]

43 16.627255C15H10O4 253.0507 (2.4)225.0741 [M–H–CO], 210.0494 [M–H–CO–CH3], 182.0542 [M–H–2CO–CH3], 154.0553 [M–H–3CO–CH3] Chrysophanol[40]

44 17.035C15H10O4 253.0512 (4.3)225.0752, 210.0474, 182.0485, 154.0531Isomer of chrysophanol[40]

45 a 17.347254, 287, 426C21H20O10 431.0989 (2.6)269.0673 [M–H–Glc], 241.0719 [M–H–Glc–CO], 225.0753 [M–H–Glc–CO2], 210.0578 [M–H–Glc–CO2–CH3], 197.0771 [M–H–Glc–CO–CO2], 182.0486 [M–H–Glc–CO2–CH3–CO] 455.1010271.0715 [M + H–Glc]+ Emodin-8-O-glucoside[41]

46 17.396240, 330, 395C15H12O4 255.0639 (−7.1)257.0812 (−0.8)Isoliquiritigenin[26]

47 a 18.385250, 304C16H12O4 267.0653 (−1.5)269.0827 (4.8)291.0751Formononetin[42]

48 18.804895.4082 (2.8)719.3849 [M–H–GlcA]351.0630 [2GlcA–H] 897.4107 (1.2)919.392522β-Acetoxy licorice saponin B2/uralsaponin F[43]

49 19.194271, 421C22H22O10 445.1168 (−5.6)283.0632 [M–H–Glc] 469.1128285.0775 [M + H–Glc]+ Physcion-8-O-β-D-glucopyranoside[41]

50 19.603248C42H60O16 819.3843 (0.6)351.0699 [2GlcA–H] 821.3994 (−0.1)843.3996645.3612 [M + H–GlcA]+, 469.3302 [M + H–2GlcA]+, 451.3211 [M + H–2GlcA–H2O]+ Licorice saponin E2[35]

51 19.704C16H24O7 327.2180 (2.8)164.9664 [M–H–Glc] 351.2133Rhododendrol-4′-O-β-D-glucopyranoside[44]

52 20.000254C44H64O18 879.4062 (1.3)351.0806 [M–H–22AG] 881.4170 (−0.1)705.3897 [M + H–GlcA]+, 529.3588 [M + H–2GlcA]+, 511.3395 [M + H–2GlcA–H2O]+ 22-Acetoxyglycyrrhizin[42]

53 20.573352C17H14O7 329.2341 (3.9)353.2280301.1443 [M + H–CH2O]+, 287.2002 [M + H–CO2]+, 259.1248 [M + H–CO2–CO]+ Tricin[45]

54 a 21.199260C15H8O6 283.0262 (6.7)239.0359 [M–H–CO2] 285.0515 (−13.0)Rhein[46]

55 21.540253837.3977 (1.2)819.4404 [M–H–H2O], 661.4100 [M–H–GlcA], 351.0815 [2GlcA–H], 289.0840 [2GlcA–H–H2O–CO2] 839.4061 (−0.5)861.3890663.3868 [M + H–GlcA]+, 487.3395 [M + H–2GlcA]+, 469.3286 [M + H–2GlcA–H2O]+ Licorice saponin G2[42]

56 21.626236, 327, 370, 384C21H20O6 367.1208 (7.1)309.1566 [M–H–CO–CH2O], 265.0635 [M–H–CO–CH2O–CO2], 221.0221 [M–H–CO–CH2O–2CO2] 369.1369 (−7.6)391.1176Glycycoumarin[47]

57 22.087249C42H62O16 821.3977 (1.7)803.4501 [M–H–H2O], 759.4542 [M–H–H2O–CO2], 645.4102 [M–H–GlcA], 627.4000 [M–H–GlcA–H2O], 469.3705 [M–H–2GlcA], 351.0809 [2GlcA–H], 289.0758 [2GlcA–H–H2O–CO2] 823.4128 (1.5)845.4557647.3797 [M + H–GlcA]+, 471.3480 [M + H–2GlcA]+, 453.3365 [M + H–2GlcA–H2O]+ Glycyrrhizic acid[48]

58 22.188252C42H62O16 821.3986 (−1.1)351.0768 [M–H–GA] 823.4134 (−2.1)845.4127647.3823 [M + H–GlcA]+, 471.3365 [M + H–2GlcA]+, 453.3324 [M + H–2GlcA–H2O]+ Licorice saponin H2[26]

59 22.389248C42H64O15 807.4197 (−0.6)745.4601 [M–H–Glc], 631.4210 [M–H–GlcA], 351.0699 [M–H–GA] 809.4410 (−0.9)831.4138Licorice saponin B2[49]

60 22.623252C42H62O16 821.3997 (0.2)351.0837 [M–H–GA] 823.4105 (−1.3)845.3900647.3838 [M + H–GlcA]+, 471.3288 [M + H–2GlcA]+, 453.3279 [M + H–2GlcA–H2O]+ Licorice saponin K2[50]

61 a 23.230288, 439C15H10O5 269.0462 (4.5)241.0669 [M–H–CO], 225.0723 [M–H–CO2], 210.0427 [M–H–CO2–CH3], 197.0695 [M–H–CO–CO2], 182.0477 [M–H–CO2–CH3–CO], 154.0552 [M–H–CO2–CH3–2CO] Emodin[40]

aCompared with reference compounds.

b22AG: 22-acetoxyglycyrrhizin; Api: apiose; Ca: caffeoyl; GA: glycyrrhetinic acid; Glc: glucose; GlcA: glucuronic acid; HCT: 4-(hydroxymethyl)cyclobutane-1,2,3-triol; HEP: 4-(hydroxyethynyl) phenol; Rha: rhamnose; RL: resorcinol; Rut: rutinose; VP: 4-vinylphenol.

Figure 3

Chemical structures of the compounds identified from LQC (except for the 7 isomers).

Figure 2

UPLC-QTOF-MS chromatograms of sample solution from negative ion mode and positive ion mode.

3.2.1. Flavonoids

Seventeen flavonoids (Figure 3(a)) in LQC including flavone aglycones and glycosides were identified. They were mainly obtained from Lianqiao, Jinyinhua, Gancao, Hongjingtian, and Mahuang. Amongst them, liquiritin apioside (22), ononin (25), hyperin (26), rutin (29), liquiritigenin (35), isoliquiritin apioside (36), isoliquiritin (37), and formononetin (47) were unambiguously identified via the standards. In negative and positive ion modes, flavone aglycones mainly gain fragment ions by the reverse Diels-Alder (RDA) reaction and the loss of CO (28 Da). The characteristic fragmentation behavior of compound 35 is shown in Figure 4(a) with high abundant fragmentation [M+H–VP (4-vinylphenol)]+ at m/z 137.0422. The abundance of fragment ions [M+H–RL (resorcinol)]+ at m/z 147.0621 and [M+H–RL–CO]+ at m/z 119.0691 is relatively lower. Compounds 24, 40, 42, and 46 were tentatively identified via comparing their exact molecular masses, MS/MS spectra data, and retention behaviors with literature data [13, 26, 39]. Flavone glycosides have the similar fragmentation pathways of simultaneous or successive loss of glucose (162 Da), rhamnose (146 Da), or apiose (132 Da). The fragmentation pathway of compound 26 was exemplified in Figure 4(b) in negative ion mode. Compounds 21, 23, 31, 41, and 53 were tentatively identified by comparing the molecular mass and MS/MS data with literature data [25, 45].
Figure 4

The MS spectra and fragmentation pathway of compound 35 (a), compound 26 (b), compound 8 (c), compound 30 (d), compound 39 (e), compound 61 (f), compound 45 (g), compound 57 (h), and compound 5 (i).

3.2.2. Phenylpropanoids

Fourteen phenylpropanoids (Figure 3(b)) including phenylpropionic acids, lignans, and coumarins were identified in LQC. They were mainly obtained from Lianqiao, Jinyinhua, and Gancao. Neochlorogenic acid (4), chlorogenic acid (8), cryptochlorogenic acid (9), 3,5-dicaffeoylquinic acid (27), forsythoside A (30), 3,4-dicaffeoylquinic acid (34), and phillyrin (39) were unambiguously characterized by comparing with standards. In negative ion mode, phenylpropionic acids have the similar fragmentation pathways of simultaneous or successive loss of H2O (18 Da), CO (28 Da), and CO2 (44 Da). The fragmentation pathway of compound 8 [18], as the representative of phenylpropionic acids, is shown in Figure 4(c). Compound 30 produced [M–H–Ca (caffeoyl)]− at m/z 461.1920 and [Caffeic–H–H2O]− at m/z 161.0328, as displayed in Figure 4(d). Lignans primarily generated [M+HCOO]− in negative ion mode and further elimination of glucose (162 Da) produced aglycone. As shown in Figure 4(e), compound 39 produced characteristic fragments at m/z 371.1826 and m/z 356.1547 corresponding to [M–H–Glc (glucose)]− and [M–H–GlcCH3]−, respectively. Compounds 16, 18, 19, 28, 32, 38, and 56 were tentatively identified on the basis of the exact molecular formulae matching, fragmentation information, and retention behaviors as well as literature data [23, 24, 33, 36, 47].

3.2.3. Anthraquinones

Eight anthraquinones (Figure 3(c)) in LQC were definitely or tentatively identified. All of them were derived from Dahuang. Chrysophanol glucoside (17), emodin-8-O-glucoside (45), rhein (54), and emodin (61) were confirmed via comparing with standard substances. The characteristic fragmentation behavior of anthraquinones was the loss of CO2 (44 Da), CH3 (15 Da), and CO (28 Da) in negative ion mode. Typical compound 61 was used to explain the fragmentation pathway of anthraquinones presented in Figure 4(f). Compound 45, as shown in Figure 4(g), produced characteristic fragments at m/z 269.0673, m/z 241.0719, m/z 225.0753, m/z 197.0771, and m/z 182.0486 which corresponded to [M–H–Glc]−, [M–H–GlcCO]−, [M–H–GlcCO2]−, [M–H–COCO2]−, and [M–H–CO2CH3CO]−, respectively. Compounds 12, 43, 44, and 49 were tentatively identified by comparing their accurate molecular masses and MS/MS fragment data with literature data [21, 40, 41].

3.2.4. Triterpenoids

Eight triterpenoids (Figure 3(d)) in LQC were unambiguously or tentatively identified. All of them were derived from Gancao. Glycyrrhizic acid (57) was confirmed by comparing with standards. In negative ion mode, representative compound 57 yielded [M–H–H2OCO2]− at m/z 759.4524, [M–H–GlcA (glucuronic acid)]− at m/z 645.4102, [M–H–2GlcA]− at m/z 469.3705, [2GlcA–H]− at m/z 351.0809, and [2GlcA–H–H2OCO2]− at m/z 289.0758, as shown in Figure 4(h). Compounds 48, 50, 52, 55, 58, 59, and 60 were tentatively identified by comparing their exact molecular masses and MS/MS spectral data with the literature data [51].

3.2.5. Iridoids

Four iridoids (Figure 3(e)) in LQC including iridoid glycosides and secoiridoid glycosides were identified. All of them were derived from Jinyinhua. Loganic acid (5), sweroside (13), and secoxyloganin (20) were unambiguously identified via the standards. The fragment 1,4F (fragment generated from the fracture of 1/4 bonds of iridoids) in the negative ion mode was identified as the characteristic fragment ion of iridoid glycosides. Meanwhile, iridoid glycosides would lose the functional groups such as H2O (18 Da), CO2 (44 Da), and glucose (162 Da). Typical compound 5 gave [M–H–GlcCO2H2O]− at m/z 151.0878, [M–H–Glc2CO2]− at m/z 125.0712, and [1,4F–H2O]− at m/z 93.0423 [52], as presented in Figure 4(i). Compound 10 was tentatively identified by comparing its exact molecular mass and MS/MS spectral data with the literature data [19].

3.2.6. Other Types of Compounds

Compounds 1, 2, 11, 14, 15, and 51 were tentatively identified by comparing their exact molecular masses and MS/MS spectral data with the literature data except gallic acid (3), salidroside (6), forsythoside E (7), and amygdalin (33) which were identified via the standards (Figure 3(f)) [12, 53].

3.3. Methodological Validation of the Quantitative Analysis

As shown in Table 3, twelve standards were of good linearity with high correlation coefficient values over 0.9993. The LODs and LOQs were 0.051–1.71 μg/mL and 0.16–5.69 μg/mL, independently. Twelve analytes in sample solution were stable at room temperature within 48 h with the RSD less than 2.76%. The RSD values of intraday and interday precisions were less than 1.10% and 2.92%, respectively. The RSD of repeatability was less than 2.39%. The average recovery rates of 12 compounds ranged from 92.99% to 103.95% with the RSD less than 3.54%. All the results showed that the assay was satisfactory with high accuracy, good reproducibility, and high sensitivity which were beneficial to the analytical investigation and quality control for LQC.
Table 3

Linear regression, LODs and LOQs, intraday and interday precisions, repeatability, stability, and recovery for 12 compounds.

Compound Regression equationa (n = 3) R 2 Linear range (μg/mL) LODb(μg/mL) LOQc(μg/mL) Intraday (RSD, %) (n = 6) Interday (RSD, %) (n = 3)Repeatability (n = 6)Stability(RSD, %)Recovery (n = 6)
Mean (μg/g) RSD (%)Original(μg)Spiked(μg)Detected(μg)Recovery(%)RSD(%)
Salidroside y = 13980x − 112650.99995.27–84.351.063.500.120.261779.55 ± 10.920.611.38355.91354.20707.5099.281.24

Chlorogenic acid y = 26510x + 3673.30.99986.85–109.561.715.690.772.122473.71 ± 12.740.512.54494.74493.85959.9094.192.42

Forsythoside E y = 11793x + 5016.80.99954.85–77.641.214.040.672.251754.03 ± 18.721.072.67351.81351.05677.2692.993.54

Cryptochlorogenic acid y = 21498x − 5018.90.99976.65–106.471.665.531.101.632029.49 ± 20.651.022.46405.90406.60784.0093.101.43

Amygdalin y = 10530x − 3464.70.99983.91–62.570.983.260.790.931485.38 ± 25.851.742.48297.08298.62576.3993.583.32

Sweroside y = 20593x − 6003.40.99992.00–31.960.250.800.110.33798.06 ± 2.930.370.48159.61159.51325.43103.950.41

Hyperin y = 27773x − 879.410.99990.20–3.210.0510.160.780.6292.03 ± 0.800.870.8318.4118.2437.07102.291.82

Rutin y = 30768x − 3783.70.99930.53–8.500.0720.210.412.24184.15 ± 3.061.661.5736.8336.8172.5096.902.34

Forsythoside A y = 8546.6x − 6024.50.99994.21–67.340.301.050.202.922484.99 ± 18.430.741.95497.00495.95997.33100.891.49

Phillyrin y = 30390x + 5282.80.99992.86–45.710.712.360.791.631577.80 ± 10.110.642.76315.56316.72623.99100.251.60

Rhein y = 7473.6x − 5172.70.99963.47–55.490.872.880.400.28681.92 ± 16.322.390.97136.38136.27273.48100.611.61

Glycyrrhizic acid y = 10296x − 6531.30.99995.27–84.350.0920.330.342.091622.75 ± 17.591.082.15324.55323.939652.16101.313.27

a y is the peak area; x is the concentration of standard solutions.

bLOD refers to the limits of detection, S/N = 3.

cLOQ refers to the limits of quantity, S/N = 10.

3.4. Sample Analysis

Twelve representative compounds in 10 batches of LQC were quantified through the developed UPLC-DAD analytical method described above. The results are summarized in Table 4, which showed that the total concentrations of 12 quantitative compounds in different batches of the LQC varied narrowly; moreover, the 12 components differed greatly in their contents, which may be affected by the source of medicinal materials, the quality of the plant material, or the preparation technology. Among them, forsythoside A showed the highest amount (3164.55–2089.22 μg/g) followed by amygdalin (2594.75–1623.14 μg/g) and hyperin had the lowest amount at 100.80–62.56 μg/g.
Table 4

Contents of the 12 compounds in 10 batches.

SampleCompound (mean ± SD) (μg/g)TotalRSD (%)
SalidrosideChlorogenic acidForsythoside ECryptochlorogenic acidAmygdalinSwerosideHyperinRutinForsythoside APhillyrinRheinGlycyrrhizic acid
Lot.11740.57 ± 30.702159.11 ± 12.471888.99 ± 7.951464.88 ± 10.222109.85 ± 31.27830.23 ± 8.4467.06 ± 0.68156.22 ± 1.113163.84 ± 33.141599.20 ± 12.29570.70 ± 2.231028.45 ± 4.2116779.1010.03
Lot.21697.04 ± 12.541810.69 ± 11.731424.67 ± 38.041167.41 ± 8.351623.14 ± 25.14650.95 ± 7.2168.07 ± 1.37106.85 ± 2.822497.34 ± 27.211220.59 ± 35.57554.26 ± 8.27837.16 ± 11.6513658.17
Lot.31456.36 ± 22.081941.91 ± 44.941477.93 ± 29.661232.30 ± 29.881641.25 ± 34.31681.53 ± 6.3572.66 ± 2.05110.31 ± 2.162089.22 ± 36.091314.99 ± 31.21617.91 ± 10.70904.75 ± 15.7313541.12
Lot.41520.75 ± 8.911993.38 ± 50.861501.09 ± 42.601409.15 ± 6.322147.01 ± 60.37743.98 ± 18.0062.56 ± 1.28100.86 ± 2.392652.53 ± 67.031139.47 ± 24.08696.42 ± 18.76985.60 ± 22.8514925.80
Lot.51593.12 ± 35.002081.89 ± 50.771626.62 ± 48.291523.11 ± 43.222282.76 ± 46.19777.98 ± 4.1875.89 ± 1.69121.06 ± 2.413072.10 ± 44.891477.18 ± 25.48686.35 ± 16.44984.79 ± 29.1316302.85
Lot.61821.34 ± 48.552436.69 ± 31.002025.28 ± 43.311494.76 ± 12.652377.04 ± 63.64860.29 ± 13.37100.80 ± 1.87145.77 ± 2.943680.72 ± 92.851991.09 ± 18.29648.86 ± 3.911057.29 ± 30.4118639.93
Lot.71474.32 ± 36.852222.61 ± 38.271372.97 ± 36.851727.36 ± 16.402594.75 ± 50.67854.30 ± 19.3177.25 ± 2.14156.90 ± 4.652987.54 ± 36.761168.12 ± 12.70551.26 ± 5.181227.74 ± 20.2416415.12
Lot.81598.66 ± 19.512183.54 ± 15.111589.79 ± 19.711721.26 ± 11.362494.81 ± 19.61824.71 ± 4.4781.26 ± 0.69174.62 ± 0.863164.55 ± 36.811277.14 ± 11.04716.94 ± 5.741220.87 ± 9.8917048.15
Lot.91535.78 ± 30.361961.72 ± 22.331789.55 ± 28.121247.34 ± 36.591824.87 ± 35.66696.40 ± 7.0873.33 ± 0.46136.23 ± 2.512823.09 ± 15.191495.85 ± 17.76625.10 ± 11.44891.45 ± 10.6015100.71
Lot.101836.41 ± 29.142216.36 ± 8.181500.75 ± 8.061670.72 ± 23.192281.74 ± 14.32809.41 ± 3.1375.33 ± 0.85134.19 ± 1.243010.34 ± 12.641204.92 ± 28.26891.01 ± 9.991176.72 ± 6.6816807.90

4. Conclusion

LQC is a commonly used Chinese medical preparation to treat viral influenza. To date, there has not been a systematical and comprehensive study on the chemical profiling and quality control method for LQC. Therefore, an accurate, sensitive, and reliable quality control procedure for LQC is in urgent need to be established. In our study, the chemical profile of LQC was thoroughly and systematically investigated by UPLC-DAD-QTOF-MS for the first time. Sixty-one compounds were unambiguously or tentatively identified. Based on the qualitative analysis, a UPLC-DAD method was established for quantitative analysis of 12 representative compounds in LQC, which has been demonstrated to be effective for the analysis of 10 batches of LQC. This developed method could be applied as an effective quality control procedure for LQC. In addition, this study would be a powerful reference for the identification of similar compounds presented here, such as flavonoids, phenylpropanoids, anthraquinones, triterpenoids, and iridoids by MS spectra.
  33 in total

1.  Differentiation of rhizoma et radix polygoni cuspidati from closely related herbs by HPLC fingerprinting.

Authors:  Guangsheng Qian; Sik-Yuen Leung; GuangHua Lu; Kelvin Sze-Yin Leung
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-08       Impact factor: 1.645

2.  Characterization of phenolic compounds in the fruits of Forsythia suspensa by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.

Authors:  Hui Guo; Ai-Hua Liu; Min Ye; Min Yang; De-An Guo
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

3.  Identification and quantification of free radical scavengers in the flower buds of Lonicera species by online HPLC-DPPH assay coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry.

Authors:  Yan-Jing Li; Jun Chen; Ying Li; Ping Li
Journal:  Biomed Chromatogr       Date:  2011-08-31       Impact factor: 1.902

4.  Simultaneous quantification of 14 bioactive constituents in Forsythia suspensa by liquid chromatography-electrospray ionisation-mass spectrometry.

Authors:  Yang Cui; Qiao Wang; Xiaowei Shi; Xiaowei Zhang; Xiaona Sheng; Lantong Zhang
Journal:  Phytochem Anal       Date:  2010 May-Jun       Impact factor: 3.373

5.  Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth.

Authors:  Hiroaki Kiyohara; Chikara Ichino; Yuka Kawamura; Takayuki Nagai; Noriko Sato; Haruki Yamada
Journal:  J Nat Med       Date:  2011-06-14       Impact factor: 2.343

6.  Simultaneous determination of 12 major constituents in Forsythia suspensa by high performance liquid chromatography--DAD method.

Authors:  Hui Guo; Ai-Hua Liu; Lie Li; De-An Guo
Journal:  J Pharm Biomed Anal       Date:  2006-12-06       Impact factor: 3.935

7.  Comparison of raw and processed Radix Polygoni Multiflori (Heshouwu) by high performance liquid chromatography and mass spectrometry.

Authors:  Zhitao Liang; Hubiao Chen; Zhiling Yu; Zhongzhen Zhao
Journal:  Chin Med       Date:  2010-08-12       Impact factor: 5.455

8.  Simultaneous qualitation and quantification of thirteen bioactive compounds in Flos lonicerae by high-performance liquid chromatography with diode array detector and mass spectrometry.

Authors:  Zheng-Ming Qian; Hui-Jun Li; Ping Li; Mei-Ting Ren; Dan Tang
Journal:  Chem Pharm Bull (Tokyo)       Date:  2007-07       Impact factor: 1.645

9.  Isolation and identification of phenolic compounds from Gynura divaricata leaves.

Authors:  Chunpeng Wan; Yanying Yu; Shouran Zhou; Shuge Tian; Shuwen Cao
Journal:  Pharmacogn Mag       Date:  2011-04       Impact factor: 1.085

10.  Separation, characterization and dose-effect relationship of the PPARgamma-activating bio-active constituents in the Chinese herb formulation 'San-Ao decoction'.

Authors:  Ling Zhou; Yu-Ping Tang; Lu Gao; Xin-Sheng Fan; Chun-Mei Liu; De-Kang Wu
Journal:  Molecules       Date:  2009-10-09       Impact factor: 4.411

View more
  24 in total

1.  Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen).

Authors:  Shuaishuai Chen; Xiaojuan Yang; Ziying Wei; Yanru Zhang; Ying Huang; Zhuo Shi; Ziteng Zhang; Jiabo Wang; Haizhu Zhang; Jianli Ma; Xiaohe Xiao; Ming Niu
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

2.  Molecular Role of EGFR-MAPK Pathway in Patchouli Alcohol-Induced Apoptosis and Cell Cycle Arrest on A549 Cells In Vitro and In Vivo.

Authors:  XinGang Lu; Liu Yang; ChengHua Lu; ZhenYu Xu; HongFu Qiu; JiaJia Wu; JingWen Wang; JiaFeng Tong; Yin Zhu; Jie Shen
Journal:  Biomed Res Int       Date:  2016-10-17       Impact factor: 3.411

Review 3.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-12

Review 4.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

5.  Development of Simultaneous Analysis of Thirteen Bioactive Compounds in So-Cheong-Ryong-Tang Using UPLC-DAD.

Authors:  Ji Hyun Jeong; Seon Yu Lee; Bo Na Kim; Guk Yeo Lee; Seong Ho Ham
Journal:  J Anal Methods Chem       Date:  2018-05-02       Impact factor: 2.193

6.  The Effects of Sweet Foods on the Pharmacokinetics of Glycyrrhizic Acid by icELISA.

Authors:  Bingqian Jiang; Huihua Qu; Hui Kong; Yue Zhang; Shuchen Liu; Jinjun Cheng; Xin Yan; Yan Zhao
Journal:  Molecules       Date:  2017-03-21       Impact factor: 4.411

7.  Quadruple therapy for asymptomatic COVID-19 infection patients.

Authors:  Ling Wang; Xiaopeng Xu; Junshan Ruan; Saijin Lin; Jinhua Jiang; Hong Ye
Journal:  Expert Rev Anti Infect Ther       Date:  2020-05-03       Impact factor: 5.091

8.  Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening.

Authors:  Xiaofei Chen; Yunlong Wu; Chun Chen; Yanqiu Gu; Chunyan Zhu; Suping Wang; Jiayun Chen; Lei Zhang; Lei Lv; Guoqing Zhang; Yongfang Yuan; Yifeng Chai; Mingshe Zhu; Caisheng Wu
Journal:  Acta Pharm Sin B       Date:  2020-10-10       Impact factor: 11.413

9.  Clinical characteristics of coronavirus disease 2019 in patients aged 80 years and older.

Authors:  Jian-Zhong Dang; Gang-Yan Zhu; Ying-Jie Yang; Fang Zheng
Journal:  J Integr Med       Date:  2020-07-10

Review 10.  Bioactive natural compounds against human coronaviruses: a review and perspective.

Authors:  Yanfang Xian; Juan Zhang; Zhaoxiang Bian; Hua Zhou; Zhenbiao Zhang; Zhixiu Lin; Hongxi Xu
Journal:  Acta Pharm Sin B       Date:  2020-06-08       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.